210 related articles for article (PubMed ID: 27621837)
1. Society for Neuro-Oncology 2014 annual meeting updates on central nervous system metastases.
Lukas RV; Mehta MP; Lesniak MS
Neurooncol Pract; 2015 Jun; 2(2):57-61. PubMed ID: 27621837
[TBL] [Abstract][Full Text] [Related]
2. Highlights of the 2019 Society for Neuro-Oncology Inaugural Brain Metastases Conference: establishing a dedicated meeting to address an unmet need in the field.
Zuccato JA; Aizer AA; Lee EQ; Ahluwalia MS; O'Halloran PJ; Mansouri A; Wen PY; Zadeh G
Neurooncol Adv; 2020; 2(1):vdaa036. PubMed ID: 32793883
[TBL] [Abstract][Full Text] [Related]
3. A selected review of abstracts from the 20th Annual Meeting of the Society for Neuro-Oncology (SNO).
Chamberlain MC
CNS Oncol; 2016 Jul; 5(3):115-9. PubMed ID: 27230972
[TBL] [Abstract][Full Text] [Related]
4. US Food and Drug Administration regulatory updates in neuro-oncology.
Mehta GU; Barone AK; Bradford D; Larkins E; Kim J; Pai-Scherf L; Jaigirdar A; Shah M; Wedam S; Amiri-Kordestani L; Theoret MR; Pazdur R; Beaver JA; Singh H
J Neurooncol; 2021 Jul; 153(3):375-381. PubMed ID: 34156585
[TBL] [Abstract][Full Text] [Related]
5. Response Assessment in Neuro-Oncology Clinical Trials.
Wen PY; Chang SM; Van den Bent MJ; Vogelbaum MA; Macdonald DR; Lee EQ
J Clin Oncol; 2017 Jul; 35(21):2439-2449. PubMed ID: 28640707
[TBL] [Abstract][Full Text] [Related]
6. Advances in brain metastases presented at the American Society of Clinical Oncology 2016 Annual Meeting: Part I.
Chen LF; Patel JD; Lukas RV
Future Oncol; 2016 Nov; 12(22):2535-2538. PubMed ID: 27595336
[TBL] [Abstract][Full Text] [Related]
7. Advances in brain metastases presented at the American Society of Clinical Oncology 2016 Annual Meeting: Part II.
Chen LF; Patel JD; Lukas RV
Future Oncol; 2016 Dec; 12(23):2669-2672. PubMed ID: 27605123
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK-positive non-small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteria.
Gandhi L; Ou SI; Shaw AT; Barlesi F; Dingemans AC; Kim DW; Camidge DR; Hughes BGM; Yang JC; de Castro J; Crino L; Léna H; Do P; Golding S; Bordogna W; Zeaiter A; Kotb A; Gadgeel S
Eur J Cancer; 2017 Sep; 82():27-33. PubMed ID: 28646771
[TBL] [Abstract][Full Text] [Related]
9. American Society of Clinical Oncology 2021 Annual Meeting updates on primary brain tumors and CNS metastatic tumors.
Baskaran AB; Kumthekar P; Heimberger AB; Lukas RV
Future Oncol; 2021 Nov; 17(33):4425-4429. PubMed ID: 34672682
[TBL] [Abstract][Full Text] [Related]
10. Commentary on 19(th) annual scientific meeting of the Society for Neuro-Oncology.
Jalali R
Indian J Med Paediatr Oncol; 2015; 36(1):63-5. PubMed ID: 25810579
[TBL] [Abstract][Full Text] [Related]
11. A selected review of abstracts from the 19th annual meeting of the Society for Neuro-Oncology.
Chamberlain MC
CNS Oncol; 2015; 4(3):125-9. PubMed ID: 25906288
[TBL] [Abstract][Full Text] [Related]
12. Imaging Criteria in Neuro-oncology.
Nowosielski M; Wen PY
Semin Neurol; 2018 Feb; 38(1):24-31. PubMed ID: 29548049
[TBL] [Abstract][Full Text] [Related]
13. Foundations of Neuro-Oncology: A Multidisciplinary Approach.
Barbaro M; Fine HA; Magge RS
World Neurosurg; 2021 Jul; 151():392-401. PubMed ID: 33618043
[TBL] [Abstract][Full Text] [Related]
14. Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies.
Popat S; Ahn MJ; Ekman S; Leighl NB; Ramalingam SS; Reungwetwattana T; Siva S; Tsuboi M; Wu YL; Yang JC
Target Oncol; 2023 Jan; 18(1):9-24. PubMed ID: 36652172
[TBL] [Abstract][Full Text] [Related]
15. A selected review of abstracts from the 17th Annual Scientific Meeting of the Society for Neuro-Oncology.
Chamberlain MC
CNS Oncol; 2013 Mar; 2(2):117-20. PubMed ID: 25057974
[TBL] [Abstract][Full Text] [Related]
16. Updates from the Neuro-Oncology Section of the 2015 American Neurological Association Annual Meeting.
Lukas RV; Wainwright DA; Laterra JJ
Future Oncol; 2016 Jan; 12(2):143-7. PubMed ID: 26616737
[TBL] [Abstract][Full Text] [Related]
17. Response assessment criteria for brain metastases: proposal from the RANO group.
Lin NU; Lee EQ; Aoyama H; Barani IJ; Barboriak DP; Baumert BG; Bendszus M; Brown PD; Camidge DR; Chang SM; Dancey J; de Vries EG; Gaspar LE; Harris GJ; Hodi FS; Kalkanis SN; Linskey ME; Macdonald DR; Margolin K; Mehta MP; Schiff D; Soffietti R; Suh JH; van den Bent MJ; Vogelbaum MA; Wen PY;
Lancet Oncol; 2015 Jun; 16(6):e270-8. PubMed ID: 26065612
[TBL] [Abstract][Full Text] [Related]
18. Management of CNS disease in ALK-positive non-small cell lung cancer: Is whole brain radiotherapy still needed?
Wrona A
Cancer Radiother; 2019 Sep; 23(5):432-438. PubMed ID: 31331844
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Brain Tumor Response: RANO and Its Offspring.
Eisele SC; Wen PY; Lee EQ
Curr Treat Options Oncol; 2016 Jul; 17(7):35. PubMed ID: 27262709
[TBL] [Abstract][Full Text] [Related]
20. Top advances of the year: Neuro-oncology.
Barden MM; Omuro AM
Cancer; 2023 May; 129(10):1467-1472. PubMed ID: 36825454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
